Silymarin for the Prevention of Contrast‑Induced Nephropathy: A Placebo‑Controlled Clinical Trial

Conclusions: We found a trend toward the efficacy of silymarin in preventing contrast‑induced renal dysfunction. Further trials with larger sample size and in patients with higher risk of CINare warranted.Keywords: Acute kidney injury, contrast media, coronary angiography, herbal medicine, silymarin
Source: International Journal of Preventive Medicine - Category: Global & Universal Source Type: research